Endurant Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-243,795
| Closed | -$322K | – | 80 |
|
|
2022
Q1 | $322K | Sell |
243,795
-116,283
| -32% | -$154K | 0.08% | 59 |
|
|
2021
Q4 | $940K | Sell |
360,078
-772,445
| -68% | -$2.02M | 0.23% | 58 |
|
|
2021
Q3 | $3.52M | Sell |
1,132,523
-997,186
| -47% | -$3.1M | 0.8% | 29 |
|
|
2021
Q2 | $7.92M | Sell |
2,129,709
-33,809
| -2% | -$126K | 2.18% | 13 |
|
|
2021
Q1 | $7.49M | Buy |
+2,163,518
| New | +$7.49M | 1.95% | 21 |
|